3.0
Feb 5, 2011
Current employee
Washington, DC
Recommend
CEO approval
Business Outlook
Pros
Scientific/technical rigor, great place to "learn" the pharmaceutical industry
Cons
Suffers from "Merck way" mentality, overly bureaucratic, committee decision making.